Literature DB >> 30100217

National trends in diabetes mellitus hospitalization in Spain 1997-2010: Analysis of over 5.4 millions of admissions.

Carmen M Lara-Rojas1, Luis M Pérez-Belmonte2, María D López-Carmona1, Ricardo Guijarro-Merino1, María R Bernal-López3, Ricardo Gómez-Huelgas3.   

Abstract

AIMS: To analyze national trends in the rates of hospitalizations (all-cause and by principal discharge diagnosis) in total diabetic population of Spain.
METHODS: We carried out a nation-wide population-based study of all diabetic patients hospitalized between 1997 and 2010. All-cause hospitalizations, hospitalizations by principal discharge diagnosis, mean age, Charlson Comorbidity Index, readmission rates and length of hospital stay were examined. Annual rates adjusted for age and sex were analyzed and trends were calculated.
RESULTS: Over 14-years-period, all-cause hospitalizations of diabetic patients increased significantly, with an average annual percentage change of 2.5 (95%CI: 1.5-3.5; Ptrend < 0.01). The greatest increase was observed in heart failure (5.4; 95%CI: 4.8-6.0; Ptrend < 0.001), followed by neoplasms (4.9; 95%CI: 3.6-5.8; Ptrend < 0.001), pneumonia (2.7; 95%CI: 2.0-4.0; Ptrend < 0.001), stroke (2.4; 95%CI: 1.6-3.4; Ptrend < 0.001), chronic obstructive pulmonary disease (2.0; 95%CI: 1.4-3.4; Ptrend < 0.001) and coronary artery disease (1.6; 95%CI: 1.1-2.3; Ptrend < 0.01). The adjusted number of all-cause hospitalizations of patients with diabetes per 100,000 inhabitants increased 2.6-fold. The increase in hospitalizations was significantly higher among patients ≥75 years old. Males experienced a greater increase in all-cause, neoplasm, heart failure, chronic obstructive pulmonary disease, and pneumonia hospitalizations (p < 0.01 for all). Hospitalized diabetic patients were progressively older and had more comorbidities, higher readmission rates and shorter hospital stays (p < 0.05 for all).
CONCLUSIONS: Hospitalizations of diabetic patients more than doubled in Spain during the study period. Heart failure and neoplasms experienced the greatest annual increases and remained the principal causes of hospitalization, probably associated with advanced age and comorbidities of hospitalized diabetics. Coronary and cerebrovascular diseases experienced a lower annual increase, suggesting an improvement in cardiovascular care in diabetes in Spain.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Cardiovascular disease; Diabetes mellitus; Heart failure; Hospitalization; Neoplasm; Trend

Mesh:

Year:  2018        PMID: 30100217     DOI: 10.1016/j.ejim.2018.04.005

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  7 in total

1.  Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study.

Authors:  Luis M Pérez-Belmonte; Julio Osuna-Sánchez; Mercedes Millán-Gómez; María D López-Carmona; Juan J Gómez-Doblas; Lidia Cobos-Palacios; Jaime Sanz-Cánovas; Miguel A Barbancho; José P Lara; Manuel Jiménez-Navarro; M Rosa Bernal-López; Ricardo Gómez-Huelgas
Journal:  Ann Med       Date:  2019-05-21       Impact factor: 4.709

2.  Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice.

Authors:  Luis M Pérez-Belmonte; Jaime Sanz-Cánovas; María D García de Lucas; Michele Ricci; Beatriz Avilés-Bueno; Lidia Cobos-Palacios; Miguel A Pérez-Velasco; Almudena López-Sampalo; M Rosa Bernal-López; Sergio Jansen-Chaparro; José P Miramontes-González; Ricardo Gómez-Huelgas
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-24       Impact factor: 6.055

3.  Trends in inpatient admissions and emergency department visits for heart failure in adults with versus without diabetes in the USA, 2006-2017.

Authors:  Jessica L Harding; Stephen R Benoit; Israel Hora; Lakshmi Sridharan; Mohammed K Ali; Ram Jagannathan; Rachel E Patzer; K M Venkat Narayan
Journal:  BMJ Open Diabetes Res Care       Date:  2021-10

4.  Reasons for Hospitalisation among Patients with Diabetes in a Secondary Care Hospital in South India: A Retrospective Study.

Authors:  Santhosh Rani; Sajitha Mf Rahman; Ruby A Pricilla; Kirubah V David
Journal:  Indian J Endocrinol Metab       Date:  2022-06-06

5.  De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF Study.

Authors:  Luis M Pérez-Belmonte; Michele Ricci; Jaime Sanz-Cánovas; Lidia Cobos-Palacios; María D López-Carmona; M Isabel Ruiz-Moreno; Mercedes Millán-Gómez; M Rosa Bernal-López; Sergio Jansen-Chaparro; Ricardo Gómez-Huelgas
Journal:  J Clin Med       Date:  2021-05-08       Impact factor: 4.241

6.  Potentially preventable urinary tract infection in patients with type 2 diabetes - A hospital-based study.

Authors:  Maria Cristina Carrondo; Joaquim Jorge Moita
Journal:  Obes Med       Date:  2020-01-28

7.  Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study).

Authors:  Luis M Pérez-Belmonte; Juan J Gómez-Doblas; Mercedes Millán-Gómez; María D López-Carmona; Ricardo Guijarro-Merino; Fernando Carrasco-Chinchilla; Eduardo de Teresa-Galván; Manuel Jiménez-Navarro; M Rosa Bernal-López; Ricardo Gómez-Huelgas
Journal:  J Clin Med       Date:  2018-09-11       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.